论文部分内容阅读
本文选用脑多肽（实验组）和脑复康（对照组）对脑血管病后学习记忆功能障碍的58例患者随机分组治疗，用CMS和WMS观察记忆改善情况，结果实验组明显优于对照组，差异显著（P＜0．05）。分析与脑多肽中含有大量的乙酰胆碱、多种氨基酸和NTFs有关。对比显示，脑多肽为治疗脑血管病后学习记忆障碍之较理想药物。
In this paper, 58 patients with learning and memory dysfunction after cerebrovascular disease were randomly divided into treatment group (experimental group) and naofukuk (control group). The improvement of memory was observed by CMS and WMS. The results of the experimental group were significantly better than those of the control group , Significant difference (P <0.05). Analysis and brain peptides contain large amounts of acetylcholine, a variety of amino acids and NTFs related. Comparison shows that brain peptides for the treatment of cerebrovascular disease learning and memory disorders more ideal drug.